ArticleFrontiers in immunology2026
SPHK1 drives pyroptosis via ROS-dependent activation of the NLRP3 inflammasome in non-infectious uveitis.
Article in Frontiers in immunology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Non-infectious uveitis associated with systemic diseases is a sight-threatening inflammatory disorder often associated with dysregulated immune responses and oxidative stress. Although redox imbalance is thought to contribute to its pathogenesis, the precise molecular mechanisms remain poorly defined. Methods: We performed transcriptomic analysis of human non-infectious uveitis datasets (GSE17114 and GSE18781) encompassing Behçet's uveitis (BU), sarcoidosis-associated uveitis, and spondyloarthropathy (SpA)-associated uveitis, combined with experimental validation to elucidate oxidative stress-associated mechanisms. Results: We identified 1,821 differentially expressed genes (DEGs) enriched in immune cell migration, T and B cell signaling, and T cell activation pathways. Among the oxidative stress-associated DEGs, six genes were validated in patients with BU: SPHK1, MMP8, and ARG1 were upregulated, while CCR7, PDGFD, and DDIT4 were downregulated. Knockdown of SPHK1 reduced ROS production, lipid peroxidation, and NLRP3 inflammasome-mediated pyroptosis, decreasing IL-1β and IL-18 secretion; SPHK1 overexpression promoted pyroptosis, reversed by the ROS inhibitor N-acetylcysteine. Molecular docking revealed strong binding affinity between SPHK1 and dexamethasone. All six oxidative stress-related DEGs demonstrated strong diagnostic potential. Immune cell abundance profiling revealed a significant decrease in activated CD4+ T cells, memory B cells, and NK cells in peripheral blood. Discussion: Collectively, our findings highlight SPHK1 as a key mediator of oxidative stress-induced pyroptosis in non-infectious uveitis and propose the SPHK1-ROS-pyroptosis axis as a potential therapeutic target.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.